Latest News and Research
Research Explores Neurocognitive Profile, Cognitive Impairment in MDD
A literature review provided new insight into the clinical neurocognitive profile in major depressive disorder (MDD) and its relationship to cognitive deficits.
FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder
Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).
Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation
Potentiating current antidepressant treatment is much needed. Based on animal studies, caffeine may augment the effects of currently available antidepressants.
TMS Condensed! Rapid Acting With Improved Remission Rates With SAINT
Richard A. Bermudes, M.D. Read Full Story Here Potentiating current antidepressant treatment is much needed. Based on animal studies, caffeine may augment the effects of currently available antidepressants. Here, we tested whether habitual caffeine consumption moderates the antidepressant effects of…
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
Nolan R. Williams, M.D. Read Full Story Here On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D., of Stanford University,…
Personalizing rTMS Parameters For Depression Treatment Using Multimodal Neuroimaging
Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD).
Neuromodulation Therapy May Improve Treatment-Resistant Depression
A high dose of intermittent theta-burst stimulation with functional-connectivity-guided targeting outperformed sham stimulation for treatment-resistant depression.
Left Dorsolateral Prefrontal Cortex rTMS in Alleviating MTBI Related Headaches and Depressive Symptoms
Persistent mild traumatic brain injury related headache (MTBI-HA) represents a neuropathic pain state.